Lifecare announced today that it has formal preparations underway to submit its implantable continuous glucose monitor (CGM) for CE mark. Bergen, Norway-based Lifecare said in a news release that it began its work on CE mark approval six weeks ago. It aims to bring its CGM system to Europe as a regulated medical device by […]
lifecare
Lifecare takes next steps in CGM implant development
Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor (CGM) implant. The Norway-based company says it completed the initial electromagnetic compatibility (EMC) testing of electronics developed for its next-generation CGM implant. EMC testing ensures that the implant can operate reliably when surrounded by mobile phones, […]
Lifecare goes public to support implantable glucose meter
Norwegian life-sciences group Lifecare AS plans to begin trading today on the Merkur Market under the ticker symbol ‘LIFE-ME’. The company is developing an implantable glucose sensor designed for people living with diabetes. “People with diabetes must watch closely their glucose levels to get the right amount of insulin at the right time. Diabetics deserve a modern […]
